Treatment of stiff-person syndrome with chronic plasmapheresis

Movement Disorders

Volumn 28, Issue 3, 2013, Pages 396-397

  De la Casa Fages, Beatriz ^a   Anaya, Fernando ^b   Gabriel Ortemberg, Martin ^b   Grandas, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE 65 ANTIBODY;

ANTIBODY BLOOD LEVEL; CASE REPORT; CENTRAL VENOUS CATHETER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; MALE; MEDICAL DEVICE; PLASMAPHERESIS; PRIORITY JOURNAL; STIFF MAN SYNDROME;

ANTIBODIES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLASMAPHERESIS; STIFF-PERSON SYNDROME;

EID: 84875508617     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25167     Document Type: Letter

References (7)

1. Vicari AM, Folli F, Pozza G, et al. Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med 1989;320:1499.
2. Harding AE, Thompson PD, Kocen RS, et al. Plasma exchange and immunosuppression in the stiff man syndrome. Lancet 1989;2:915.
3. Gordon MF, Pullman S, McDonald T, Fahn S. Plasmapheresis in the treatment of Stiff-man syndrome. Neurology 1991;41(Suppl 1):223.
4. Brashear HR, Phillips LH 2nd. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 1991;41:1588-1592.
5. Nakamagoe K, Ohkoshi N, Hayashi A, et al. Marked clinical improvement by plasmapheresis in a patient with stiff-man syndrome: a case with a negative anti-GAD antibody. Rinsho Shinkeigaku 1995;35:897-900.
6. Hao W, Davis C, Hirsch IB, et al. Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. J Neurol 1999;246:731-735.
7. Shariatmadar S, Noto TA. Plasma exchange in stiff-man syndrome. Ther Apher 2001;5:64-67.